https://www.selleckchem.com/products/ve-822.html
We demonstrate the utility of this tool in resolving ambiguous clinical cases and identification of previously undiagnosed cases through mass screening of a large cohort of subjects with developmental delays and congenital anomalies. This study more than doubles the number of published syndromes with DNA methylation episignatures and, most significantly, opens new avenues for accurate diagnosis and clinical assessment in individuals affected by these disorders. Genome-wide CRISPR screens enable systematic interrogation of gene function.
Like
Comment
Share
